MAZZAGLIA, GIAMPIERO
 Distribuzione geografica
Continente #
NA - Nord America 21.531
AS - Asia 16.189
EU - Europa 10.480
SA - Sud America 2.601
Continente sconosciuto - Info sul continente non disponibili 1.400
AF - Africa 335
OC - Oceania 24
Totale 52.560
Nazione #
US - Stati Uniti d'America 19.404
SG - Singapore 5.770
IT - Italia 3.541
VN - Vietnam 2.933
HK - Hong Kong 2.822
CN - Cina 2.525
BR - Brasile 2.043
RU - Federazione Russa 1.915
CA - Canada 1.881
IE - Irlanda 1.331
SE - Svezia 855
DE - Germania 792
FR - Francia 494
UA - Ucraina 453
BD - Bangladesh 450
GB - Regno Unito 437
IN - India 325
KR - Corea 262
AR - Argentina 239
ID - Indonesia 197
FI - Finlandia 181
IQ - Iraq 139
TR - Turchia 117
MX - Messico 107
NL - Olanda 104
ZA - Sudafrica 104
PK - Pakistan 91
EC - Ecuador 83
SA - Arabia Saudita 82
PH - Filippine 77
JP - Giappone 63
AT - Austria 60
CO - Colombia 59
PL - Polonia 52
ES - Italia 51
UZ - Uzbekistan 49
VE - Venezuela 44
MA - Marocco 43
EG - Egitto 41
MY - Malesia 41
CL - Cile 38
CH - Svizzera 37
PY - Paraguay 37
BE - Belgio 35
KE - Kenya 27
NP - Nepal 27
JO - Giordania 26
TN - Tunisia 25
CR - Costa Rica 24
JM - Giamaica 24
AU - Australia 23
UY - Uruguay 22
PE - Perù 20
CZ - Repubblica Ceca 19
LB - Libano 19
AE - Emirati Arabi Uniti 18
TH - Thailandia 18
DO - Repubblica Dominicana 17
IL - Israele 17
AL - Albania 16
DZ - Algeria 15
ET - Etiopia 15
IR - Iran 15
RO - Romania 15
KZ - Kazakistan 14
OM - Oman 14
DK - Danimarca 13
GT - Guatemala 13
TT - Trinidad e Tobago 13
AZ - Azerbaigian 12
BO - Bolivia 11
LT - Lituania 11
PT - Portogallo 11
NG - Nigeria 10
TW - Taiwan 10
HN - Honduras 9
NI - Nicaragua 9
PA - Panama 9
EU - Europa 8
MU - Mauritius 8
PS - Palestinian Territory 8
BH - Bahrain 7
LY - Libia 7
CI - Costa d'Avorio 6
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
MD - Moldavia 6
NO - Norvegia 6
PR - Porto Rico 6
SV - El Salvador 6
AO - Angola 5
BY - Bielorussia 5
GY - Guiana 5
KW - Kuwait 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BG - Bulgaria 4
Totale 51.093
Città #
Hong Kong 2.792
Singapore 2.622
Fairfield 1.717
Toronto 1.714
Ashburn 1.612
Ann Arbor 1.324
Dublin 1.288
Houston 1.235
Milan 990
San Jose 919
Woodbridge 888
Ho Chi Minh City 864
Santa Clara 711
Seattle 670
Wilmington 659
New York 651
Hanoi 648
Dearborn 639
Princeton 575
Cambridge 548
Chandler 493
Frankfurt am Main 479
Chicago 439
The Dalles 388
Council Bluffs 378
Jacksonville 375
Rome 375
Dallas 296
Lauterbourg 285
Moscow 282
Beijing 278
Los Angeles 260
Nanjing 244
Seoul 240
Altamura 221
Lawrence 201
Dong Ket 191
São Paulo 170
Hefei 166
Helsinki 127
Buffalo 120
Andover 108
San Diego 100
Haiphong 93
Boardman 92
Da Nang 88
Jakarta 87
Columbus 84
London 76
Rio de Janeiro 74
Shanghai 73
Guangzhou 70
Turin 66
Figino 63
Munich 62
Nuremberg 61
Changsha 59
Orem 57
Baghdad 55
Ha Long 54
Shenyang 54
Bologna 53
Nanchang 53
Hebei 52
Tianjin 49
Tokyo 49
Biên Hòa 48
Ninh Bình 48
Curitiba 46
Brooklyn 45
Naples 45
Ottawa 45
Salt Lake City 43
Jinan 42
Florence 41
Jiaxing 41
Can Tho 40
Johannesburg 39
Hải Dương 38
Quận Bình Thạnh 37
Tashkent 37
Phoenix 36
Jeddah 34
Mexico City 34
Thái Nguyên 34
Verona 33
Palermo 32
Brasília 31
Falls Church 31
Mumbai 31
Philadelphia 31
Atlanta 30
Lahore 30
Belo Horizonte 29
Perugia 29
Quito 29
Chennai 28
Dhaka 28
Porto Alegre 28
Washington 28
Totale 32.027
Nome #
Triage and Evaluation of Potential Safety Signals Identified from Electronic Healthcare Record Databases 706
Intervention studies in drug utilisation research 566
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings from 2010 to 2019 560
Epidemiology of SLE in Italy: an observational study using a primary care database 557
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project 548
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 484
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 436
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 403
Valutazione del controllo della malattia da reflusso gastroesofageo in Medicina Generale attraverso l’utilizzo del questionario “GERD Impact scale” 386
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 385
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 382
Use of computerised general practice database for epidemiological studies in italy: a comparative study with the official national statistics 371
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 362
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 358
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 293
User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures 285
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 285
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 284
Discontinuity and failures of therapy with bisphosphonates: Joint assessment of predictors with multi-state models 279
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 271
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection 260
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 259
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 258
The role of electronic healthcare record databases in paediatric drug safety surveillance: A retrospective cohort study 255
Risk of severe upper gastrointestinal complications among oral bisphosphonate users 254
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 251
Harmonisation of Outcome Estraction for Hearth Failure across Data Sources in the SAFEGUARD Project 248
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 246
Prescribing pattern of antipsychotic drugs during the years 1996–2010: a population-based database study in Europe with a focus on torsadogenic drugs 241
Azithromycin use and covid-19: a real-world observational study. 238
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 237
Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study 232
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 231
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 230
Using real-world healthcare data for pharmacovigilance signal detection-the experience of the EU-ADR project 229
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study 228
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 228
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 226
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 225
Cardiovascular diseases burden in Italy, 1990–2017: the Global Burden of Disease Study 221
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 220
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project 218
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection 217
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey 216
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases 216
Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial 214
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 212
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 211
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs 211
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients 211
Immeasurable time bias nello studio dell'associazione tra utilizzo di bifosfonati orali e rischio di sanguinamento gastrointestinale. 209
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 208
Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: A validation study 208
Assessing the risk of osteonecrosis of the jaw (onj) due to bisphosphonates (bp) therapy in the secondary prevention of osteoporotic fractures 208
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries 207
Screening of older community-dwelling people at risk for death and hospitalization: The assistenza socio-sanitaria in italia project 207
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 206
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' 205
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? 204
Use of azithromycin and risk of ventricular arrhythmia 203
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries 203
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 202
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care 202
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 202
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in rats 202
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks and public health considerations 202
Need and disparities in primary care management of patients with diabetes 202
Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor-induced inhibition of water intake in the rat 201
Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations 200
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study 200
Harmonisation of the Event Identification Process in Eight European Healthcare Databases: the experience from the EU-ADR Project. 198
Workshop: Indicatori di appropriatezza prescrittiva a sostegno delle politiche sanitarie. Relazione: Valutazione dell’impatto di programmi di minimizzazione del rischio: principi pratici e applicabilità degli indicatori di appropriatezza 198
Suboptimal Gastroprotective Coverage of NSAID Use and the Risk of Upper Gastrointestinal Complications 197
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics 194
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 194
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network 193
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 189
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease 188
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study 187
Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods 186
Development and Validation of a Score for Adjusting Health Care Costs in General Practice 186
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures 186
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study 185
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 183
Uso degli antidepressivi in Italia: un’analisi nel contesto della Medicina Generale 183
Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases 183
Pattern of antimicrobial drug prescribing and prescriptive behaviour for acute otitis media among physicians in Sicily 183
A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care 182
Risk management and drug utilization research 181
Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: A focus on elderly with dementia 180
Chair sessione: storia della sanita’ pubblica II 180
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study 179
Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance System 177
Hypertension in dialysis patients 177
A cross-sectional survey on benzodiazepine use among older people in an Italian region 177
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective 175
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study 173
Antibiotic prescribing for dental conditions: A community-based study in southern Italy 172
Drug utilization research and risk management 172
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? 172
Totale 24.735
Categoria #
all - tutte 190.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.063 0 290 273 165 116 176 128 130 111 76 119 479
2022/20233.413 673 917 287 176 165 628 37 130 220 56 74 50
2023/20243.459 64 116 115 118 556 836 659 94 530 82 76 213
2024/20259.562 509 1.508 450 403 820 226 302 246 1.348 1.180 936 1.634
2025/202620.897 2.285 1.925 1.531 1.955 1.594 913 2.445 1.043 1.614 1.500 2.299 1.793
2026/20271.702 771 931 0 0 0 0 0 0 0 0 0 0
Totale 52.560